Celldex Therapeutics shares owned by Benchmark Capital Advisors
Quarter-by-quarter ownership of Celldex Therapeutics shares owned by Benchmark Capital Advisors
from 13F filings
Historical chart of Benchmark Capital Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Benchmark Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Benchmark Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2018-12-31 | $5.9k | 33k | 0.18 |
| 2018-09-30 | $24k | 53k | 0.45 |
| 2018-06-30 | $27k | 54k | 0.50 |
| 2018-03-31 | $128k | 55k | 2.33 |
| 2017-12-31 | $173k | 61k | 2.84 |
| 2017-09-30 | $185k | 65k | 2.85 |
| 2017-06-30 | $160k | 65k | 2.47 |
| 2017-03-31 | $234k | 65k | 3.61 |
| 2016-12-31 | $236k | 67k | 3.53 |
| 2016-09-30 | $271k | 67k | 4.04 |
| 2016-06-30 | $294k | 67k | 4.39 |
| 2016-03-31 | $274k | 73k | 3.78 |
| 2015-12-31 | $316k | 20k | 15.68 |
More positions owned by Benchmark Capital Advisors
View all positions for Benchmark Capital Advisors